Best Stocks Right February: Two Power Picks for Market Rally
February can test nerves, but smart stock selection pays off. Here are two robust candidates that align with the curr...
Explore how glide paths and passive retirement options work, including risk and cost differences. This intro helps you compare pros and cons before choosing a strategy.
26,696 articlesFebruary can test nerves, but smart stock selection pays off. Here are two robust candidates that align with the curr...
Hyperliquid's native token continues a sharp weekly decline, reviving bearish bets as traders weigh on-chain signals ...
Merck stock jumps on a major restructuring, but Reddit sentiment shows growing skepticism as investors weigh Keytruda...
Beyond shakes up its identity, dropping meat from its name to chase a broader plant protein future as plant-based sal...
Cruise stocks are among the S&P 500’s biggest decliners as Middle East tensions and higher fuel costs bite into deman...
Ulta Beauty beat earnings and revenue expectations in the latest quarter, but investors focused on margin pressure an...
Hong Kong’s RedotPay is exploring a fundraising round of up to $150 million ahead of a potential U.S. IPO, according ...
Novo Nordisk has drifted toward a five-year low, raising questions about value vs. risk. This guide breaks down the f...
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Immersed, a private VR work platform behind the work-from-VR trend, is closing its under-$1 retail round. Early metri...
Remax Holdings posted a revenue decline and a sharper net loss in Q1 2026, while debt rose to $436 million. Real Brok...
Nebius Group delivered a blowout Q1 2026, with revenue growth of 684% and a high-stakes push from NVIDIA and Meta, tr...